Visualitza per autor "Ciuleanu, Tudor"
Ara mostrant els elements 1-3 d 3
-
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Felip Font, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Laktionov, Konstantin; Szilasi, Maria; Cobo, Manuel (Elsevier, 2020-03-01) -
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
Ready, Neal; Audigier-Valette, Clarisse; Goldman, Jonathan W.; Felip Font, Enriqueta; Ciuleanu, Tudor; Garcia Campelo, Rosario (BMJ, 2023-02) -
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
Reck, M.; Ciuleanu, Tudor; Schenker, M.; Zurawski, B.; Menezes, J.; Felip Font, Enriqueta; Cobo, Manuel (Elsevier, 2021-10)